Skip to content

A Prospective Study to Determin the Impact of Time-Acupoints-Space Acupuncture (ATAS) Treatment on Reducing Adverse Effects in Patients With Breast Cancer Undergoing and After Chemotherapy

A Prospective Study to Determin the Impact of Time-Acupoints-Space Acupuncture (ATAS) Treatment on Reducing Adverse Effects in Patients With Breast Cancer Undergoing and After Chemotherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17013652
Enrollment
Unknown
Registered
2017-12-03
Start date
2017-12-10
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

ATAS group:ATAS
sham acupuncture group,:sham acupuncture

Sponsors

Yunnnan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients voluntarily join the clinical trial and sign the consent form; 2. Patients aged 18-70 years old; 3. The pathological diagnosis was primary breast cancer, no evidence of distant metastases; 4. The patients need to receive neoadjuvant or adjuvant chemotherapy, and choose EC or EC-T chemotherapy regiment; 5. The patients assessed by cognition of acupuncture questionnaire; 6. The patients voluntarily accept acupuncture treatment and stick to clinical trials, from the mental states and physical condition; 7. KPS> 70; 8. Blood routine, liver and kidney test results suggest no chemotherapy contraindication.

Exclusion criteria

Exclusion criteria: 1. The patients with other chronic diseases and in non-stable phase, may aggravate the chemotherapy side effects; 2. Patients with the second primary tumors, or combined with contralateral breast cancer; 3. Serious heart condition, such as myocardial infarction, angina in the past 6 months; 4. A variety of complications, such as hepatic encephalopathy, gastrointestinal bleeding, and hypersplenism; 5. Have a history of severe allergy or idiosyncrasy; 6. Drug abuse or alcohol addiction; 7. The patients present with personality or mental illness, no capacity for civil conduct or with limited capacity for civil conduct.

Design outcomes

Primary

MeasureTime frame
Fatigue;

Secondary

MeasureTime frame
Adverse effect;Qulity of life;anxiety;depression;

Countries

China

Contacts

Public ContactWei-Hui LI

Yunnnan Cancer Hospital

wenhuili2014@163.com+86 13888087323

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 25, 2026